By Abigail Townsend
Date: Wednesday 05 Jun 2024
(Sharecast News) - Liquid biopsy specialist Angle is to raise more than £10m to support future growth, the UK company announced on Wednesday.
By Benjamin Chiou
Date: Thursday 16 May 2024
(Sharecast News) - Angle, the AIM-listed liquid biopsy company which specialises in circulating tumour cell (CTC) solutions, has announced the results of a clinical study which show that its Parsortix system could be used to predict progression-free survival in patients with ovarian cancer.
By Iain Gilbert
Date: Friday 03 May 2024
(Sharecast News) - Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.
Currency | UK Pounds |
Share Price | 14.63p |
Change Today | 0.38p |
% Change | 2.63 % |
52 Week High | 31.35 |
52 Week Low | 9.24 |
Volume | 656,894 |
Shares Issued | 322.64m |
Market Cap | £47.19m |
RiskGrade | 312 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
17:05 | 10,000 @ 14.63p |
16:29 | 34,917 @ 14.32p |
16:28 | 34,768 @ 14.38p |
16:25 | 10,000 @ 14.47p |
16:16 | 34,805 @ 14.38p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Jan Groen |
You are here: research